The purposes of this study were to identify the cognitive status of cancer survivors, determine the effect of cognitive status on function and participation in daily activities, and explore how cancer survivors perceive changes in their cognition. The study used a quantitative nonexperimental cross-sectional design. The participants included 35 cancer survivors from two different sites. Instruments included the Montreal Cognitive Assessment (MoCA) and the Reintegration to Normal Index-Postal Version (RNLI-P) in the measurement of cognitive impairment and functional performance respectively. Data were also collected with a supplemental questionnaire to explore participants' perspectives on their cognitive difficulties and current function. The participant scores on the MoCA indicated cognitive impairment (µ= 25) and their scores on the RNLI-P demonstrated subpar reintegration (µ=9.64). Twenty-one participants answered the supplemental questionnaire. In content analysis of questionnaire responses, 17/21 participants reported some level of cognitive change related to cancer and cancer treatment.
Advances in research and treatment techniques have resulted in a growing number of cancer survivors (Cohen, 2010) . However, with these new advancements come new concerns.
Changes in cognition have been identified as an effect of cancer treatment in an estimated one-third of cancer patients and survivors (Raffa et al., 2006) .
Research has shown that symptoms associated with mild cognitive impairments (MCIs), including difficulty with new learning, forgetfulness, and managing daily activities, are prevalent among cancer survivors (Baxter, Dulworth, & Smith, 2011; Jenkins et al., 2006; Tannock, Ahles, Ganz, & van Dam, 2004) . Consequently, a concern for cancer survivors is how cognitive impairments might affect their function and life participation after treatment.
To date, there has been limited research on how cognitive changes caused by cancer treatment affect survivors' participation in daily activities. Tannock et al. (2004) found that cancer survivors had concerns about cognition, in particular memory and concentration, following treatment. Ahles and Saykin (2001) noted similar findings across patients with different cancers who received systematic standard-dose chemotherapy.
Background

Cognitive Changes and Daily Function
The participants in the study by Ahles and Saykin reported that cognitive impairments interfered with their career and educational goals, as well as with everyday functioning. In a more recent study, Baxter et al. (2011) found that of 38 participants, several encountered a decrease or change in their participation in everyday life, including physical and leisure activities. In a longitudinal randomized study, Kvale et al. (2010) determined that participants showed cognitive impairments that led to difficulty with instrumental activities of daily living (IADLs), particularly those associated with driving. These difficulties contributed to disabilities among the participants by affecting their ability to perform daily tasks.
Much of the research involving cancerrelated cognitive impairment is found in studies with breast cancer survivors. For example , Jenkins et al. (2006) reported that of 128 breast cancer survivors, 83% noticed changes in memory and 80% noticed a change in concentration. These changes decreased to 60% and 45%, respectively, after three years. In another study of 52 breast cancer survivors, 17-25% showed significant cognitive impairments following cancer treatment (Von Ah et al., 2009) . Reid-Arndt, Hsieh, and Perry (2010) demonstrated that cognitive impairments continue to be prevalent up to one year after treatment has ended. Moreover, these impairments have been shown to have an effect on daily tasks, such as the ability to make employment decisions and return to work (Munir, Burrows, Yarker, Kalawsky, & Bains, 2010) . Breast cancer patients have also expressed similar cognitive dysfunctions after receiving adjuvant therapy (i.e., additional chemotherapy, radiation, or other treatment) to decrease cancer reoccurrence. In a study by Shilling and Jenkins (2007) , 142 breast cancer patients reported cognitive impairments, particularly with memory (71%) and concentration (64%). The use of Tamoxifen, an anti-estrogen drug taken by premenopausal breast cancer patients, has been shown to result in widespread cognitive impairments (Palmer, Trotter, Joy, & Carlson, 2008) .
Cancer survivors across many diagnoses, including gastrointestinal, lung, lymphoma, head and neck, prostate, and breast cancer, have reported difficulties with activities requiring cognitive functioning many months and years after completing treatment (Mah, Bezjak, Loblaw, Gotowiec, & Devins, 2011) . Grosshans, Meyes, Allen, Davenport, and Komaki (2008) found that persons with lung cancer receiving radiation showed a decrease in both executive function and language. It has also been estimated that 15% of persons with small-cell lung cancer may experience cognitive impairments following treatment (Kanard, Frytak, & Jatoi, 2004) . In a study by Schagen et al. (2008) , 50% of testicular cancer survivors (N = 70) reported cognitive impairments following chemotherapy treatment. In addition, difficulties with verbal memory and motor speed were evident in persons diagnosed with lymphoma cancers for up to two years following treatment (Correa et al., 2009 ).
MCI and Daily Function
MCI is defined as an intermediate clinical state between normal cognitive function and dementia that focuses primarily on memory, concentration, and attention (Petersen, 2004) . In recent years, it has been researched as a diagnostic entity to be used with a variety of populations, including the cancer population. Results of a study by Tuokko (2007) found that 69% of participants with MCI (N = 101) demonstrated functional impairment, particularly involving memory and executive function. In a study by Baxter et al. (2011) , of the 25 cancer patients reporting difficulty with memory, planning, or attention, 36% scored as having a mild cognitive impairment. Farias et al. (2006) ; Perneczky et al. (2006); and Artero, Touchon, and Ritchie (2001) all concluded that persons with MCI are affected by cognitive impairments, which can result in a wide range of deficits in everyday life. Kurz, Pohl, Ramsenthaler, and Sorg (2009) have suggested that MCI interferes with social planning, such as structuring and maintaining social contacts.
Maintaining the social aspects of life is an important domain in quality of life (QoL) among cancer survivors (Bloom, Petersen, & Kang, 2007) . In a large study of breast cancer survivors receiving adjuvant and/or Tamoxifen therapy (N = 763), 30% were shown to have poorer functioning on several dimensions of QoL (Ganz et al., 2002) .
More specifically, Okonkwo, Wadley, Griffith, Ball, and Marson (2006) Chirikos, Russell-Jacobs, and Jacobsen (2002) reported that these impairments are likely to affect work effort and earnings. In a study investigating persons with MCI and money management, Okonkwo et al. (2006) found that persons with MCI made more errors affecting work effort, earnings, and overall economic status. Persons with MCI also have increased difficulty using technology, such as cell phones, remote controls, microwave ovens, and computers. These technological tools are important for daily life, and difficulty using them can impede daily function and participation (Rosenberg, Kottorp, Winblad, & Nygard, 2009 
Method
Purpose of Study
Initially, this study had two purposes. The 
Research Design
This study used a nonexperimental crosssectional design to explore quantitative data relevant to cancer-related cognitive changes.
Measures were taken for attention, concentration, executive function, memory, calculation, and orientation related to mild cognitive impairment, as well as how well the participants engaged in daily activities. Data gathered by questionnaire included participants' perceptions of how cancer treatments and MCI affected their daily routines and participation in activities. This study was a collaborative project completed in Towson, Maryland, and Houston, Texas.
Participants
The participants recruited for this study were adult cancer survivors. The operational definition of cancer survivor was an individual with a diagnosis of cancer who had completed primary treatment for cancer. Inclusion criteria were that participants had the physical language and visual abilities needed to complete the assessments. No exclusion criteria were placed on cancer type, gender, ethnicity, or adult age.
Instruments
The instruments used included the Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) , the Reintegration to Normal Living Index-Postal Version (RNLI-P) (Daneski, Coshall, Tillingand, & Wolfe, 2003) , and a supplemental questionnaire. The MoCA is a screening tool designed to detect MCI that takes approximately 10 min to administer. The tool assesses different Spitzer, 1988) . The RNLI used a visual analog scale to assess participants' perceptions on 11 declarative statements representing domains of daily functioning (e.g., mobility and self-care), daily activities (e.g., work, recreational, and social activities), roles and personal relationships, and general coping skills. The RNLI was found to have an internal consistency, as measured by Cronbach's alpha, of 0.90 (Wood-Dauphinee et al., 1988 ) and a concurrent validity of 0.72 (Spitzer, Dobson, & Hall, 1981) .
In 2003, the RNLI was revised as a postal version and was renamed the RNLI-P. To complete the RNLI-P, the participants answer 11 questions by choosing "agree" or "disagree" (Daneski et al., 2003) . One point is given for each agree statement, and zero points for each disagree statement. The lowest score possible is a 0. The highest score, 11, indicates maximum integration. Reliability measures have shown that the RNLI-P is an excellent measure of reintegration into life following a traumatic event or injury. The test-retest reliability of the RNLI-P, as measured by the kappa level, is 0.92 (Daneski et al., 2003) .
The supplemental questionnaire was designed by the researchers (and had been used in a previous study) to obtain more in-depth information regarding the participants' perceptions of cognitive dysfunction and their current abilities to function and participate (Baxter et al., 2011) (Bernard, 2013) .
Responses to the open-ended question of the supplemental questionnaire were coded and assigned to categories. Frequencies of data were then computed.
Results
The participants for the study included 35 adult cancer survivors; 12 participants were from the Northeast (Towson), and 23 participants were from the South (Houston). Demographic data for the participants are shown in 
MoCA Scores
The scores obtained from the MoCA ranged from 20 to 29, with a mean score of 25.0 (SD ± 2.5).
Of the 35 participants, 22 (62.9%) scored 25 or below, and 13 (37.1%) scored 26 or above. The scores for each section were evaluated and compared with the total points possible in each section. The three sections of the MoCA with the lowest percentage of correct scores were delayed recall (20%), visuospatial/executive function (37.1%), and language (45.7%). Attention and abstraction both had scores of 57.1% correct.
Naming and orientation both had scores of 91.4%
correct.
A Pearson product-moment correlation coefficient was computed to assess the relationship between MoCA scores and time since last treatment. As noted in Table 1 , time since last treatment ranged from less than one year (n = 13) to 10 or more years (n = 7). There was no correlation between MoCA and time since last treatment [r =
.102, p = .558].
RNLI-P Scores
The scores on the RNLI-P ranged from six to 11 (Table 2) , with a mean score of 9.64 (SD ± 1.12). Of the 35 participants, four (11.4%) scored an 11 on the RNLI-P, which indicated full reintegration into daily living. The majority of the respondents indicated less than optimal integration.
Of the specific statements asked, 29 (82.9%) disagreed with the statement, "I feel embarrassed when I am with other people." All other statements had fewer than four (11.4%) participants in disagreement. The MoCA and the RNLI-P scores were compared and yielded a correlation of r = .04, p = .818. (Table 3) . Decreased participation was the most frequently reported change; the participants stated it was due to decreased energy or fatigue and/or taking longer to perform activities. Three participants reported that they were "very tired most days," while two participants expressed that they "took more naps."
One participant eloquently summed up what many of the others expressed with the statement, "slower, less energy in general." Note. The supplemental questionnaire was administered to Houston participants only. Twenty-one of the 23 participants answered the supplemental questionnaire. *Percentages total more than 100%; some participants identified more than one category of concern.
The next largest number of responses related established that a significant percentage of the cancer survivors believed they had trouble with memory, planning, or attention. These findings support previous studies in which cancer survivors self-reported or presented with symptoms of MCI (Ahles & Saykin, 2001; Baxter et al., 2011; Reid-Arndt et al., 2010; Shilling & Jenkins, 2007; Tannock et al., 2004; Von Ah et al., 2009) .
No correlation was found between the MoCA scores and the RNLI-P scores. It is possible that the RNLI-P is not sensitive enough to detect subtle changes and allow for correlation analysis.
Although the analysis showed no relationship between the MoCA and the RNLI-P scores, 31 of the 35 participants had scores on the RNLI-P that indicated that they believed they were not reintegrated into normal living. These results suggest that cancer survivors have potential difficulty in returning to normal routines. This is supported in the literature, which indicates that people with memory difficulties experience problems participating in normal routines, work, and social functions (Artero et al., 2001; Farias et al., 2006; Perneczky et al., 2006) .
Performance skills that decrease participation in daily life are areas of concern for occupational therapy practitioners (American A number of the participants (28.6%) were aged 70 years and older. Cognitive decline with aging is a frequent concern in research with older adults, and age-related cognitive decline may have contributed to the results of the study. However, as previously mentioned, the MoCA has been demonstrated to be sensitive in identifying MCI in aging adults when they are compared to agematched controls and age-matched persons diagnosed with dementia (Nasreddine et al., 2005) .
Also, three of the 10 participants aged 70 years and older had MoCA scores above 26.
A further limitation is that researchers did not obtain the participants' prior level of cognitive functioning. Several studies have indicated that obtaining a baseline for cognition in the cancer population is difficult because the psychological effects of stress, anxiety, and depression related to a cancer diagnosis can result in cognitive changes (Vardy, Rourke, & Tannock, 2007) . Therefore, although decreased cognitive status is evident in many cancer survivors, it is difficult to attribute changes in cognitive status specifically to cancer and cancer treatments. Finally, a limitation is that question number 10 on the RNLI-P is worded in a negative manner compared to the other questions on the RNLI-P. (Chirikos, et al., 2002; O'Connor et al., 2010; Okonkwo et al., 2006; Rosenberg et al., 2009 ). Furthermore, changes in activity, participation level, and routines are frequent in older cancer survivors (Lyons et al., 2013 
Future Research
Suggestions for future studies include the need for a large-scale study of MCI in cancer survivors across specific diagnoses, and the need to examine the influence of gender, race, and age. A longitudinal study would be ideal for determining the long-term cognitive effects of cancer treatment, yet a cross-sectional study with a larger population would be more feasible and would generate similar data. In addition, researchers should examine the relationship among specific cancer treatments and MCI, and determine the best instrument to measure participation in daily routines. Last, but most important, it is necessary to establish best practices to increase participation in everyday activities for cancer survivors experiencing MCI.
Conclusion
The results of this study add to the growing body of knowledge indicating that cancer survivors
show MCIs, specifically in memory, executive function, and visual/spatial processing. There also appears to be a connection between MCI and a selfreported decrease in participation in daily activities, specifically IADLs. These findings suggest that rehabilitation for cancer survivors should include an evaluation for cognitive function and interventions that focus on the promotion of strategies to improve function and increase participation in daily routines.
As the number of cancer survivors increases, occupational therapy practitioners can play an important role in cognitive rehabilitation and reintegration into daily living.
